NLSP

0.1494

2.33% +0.0034

Pre-mercato: .1685 0.0191 +12.78%

NLS Pharmaceutics Ltd (NLSP)

Panoramica Notizia Cronologia dei prezzi Perché NLSP Giù? Forum Previsione

Precedente Chiudi:

$0.146

Aprire:

$0.1366

Volume 24 ore:

1.38M

Capitalizzazione di mercato:

$6.47M

Reddito:

Utile/perdita netta:

$-15.47M

Rapporto P/E:

-0.1779

EPS:

-0.84

Flusso di cassa netto:

$-13.51M

1 W Prestazione:

+5.58%

1M Prestazione:

+9.05%

6M Prestazione:

-53.31%

1 anno Prestazione:

-86.42%

Intervallo 1D:

$0.136

$0.1899

Portata 52W:

$0.113

$1.53

NLS Pharmaceutics Ltd Stock (NLSP) Company Profile

Nome

NLS Pharmaceutics Ltd

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

41 44 512 21 50

Indirizzo

The Circle 6, Zurich

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

NLSP's Discussions on Twitter

NLS Pharmaceutics Ltd Borsa (NLSP) Ultime notizie

NLS Pharmaceutics Extends Loan Maturity Date - TipRanks.com - TipRanks

TipRanks

NLS Pharmaceutics Announces Over Enrollment in its Phase 2a Clinical Trial Evaluating Quilience(R) for the ... - The Globe and Mail

The Globe and Mail

NLS Pharmaceutics Successfully Appeals Nasdaq Delisting Notice - The Globe and Mail

The Globe and Mail

NLS Pharmaceuticals to Reschedule Company Update on Strategic Discussions - The Globe and Mail

The Globe and Mail

Chronic Fatigue Syndrome Market to Witness Growth by 2032 | AIM Immunotech, Cortene, NLS Pharmaceutics - openPR

openPR